A Phase I, Double-Blind, Placebo-Controlled, Randomised, Group Comparative Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Assending Doses of AZD9056 in Healthy Volunteers

Study identifier:D1520C05216

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Double-Blind, Placebo-Controlled, Randomised, Group Comparative Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Assending Doses of AZD9056 in Healthy Volunteers

Medical condition

Rheumatoid Arthritis

Phase

Phase 1

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Oct 2002
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria